Dokter Julie BASTIN
ActiveDokter Julie BASTIN has been active since 2018 and the Belgian State Gazette contains no insolvency or warning signals. The 2024 annual accounts show equity of €172k and a net result of €152k. Equity is growing by ~13.6% per year across the filed fiscal years. Its solvency ranks better than 90% of 2151 sector peers (fiscal year 2024). The computed 12-month bankruptcy probability is 0.1% (very low).
Checked score
Score 2024
98
/ 100
Excellent
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2023
Profitability100=
Solvency100=
Growth78=
Track record100
Bankruptcy probability, 12 months
0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €16k at 30 days acceptable
Liquidity ample (current ratio 14.33; short-term debt: 6.5% and cash: 42.4% of total assets), and 6.5% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies
more bankruptcies →
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2024Solvency, return and age of the figures
Solvency
93.5%
Return on assets
82.9%
Age of the figures
20 mo
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 30-07-2025, 1 day ahead of the deadline.
NBB · 7 filingsDeviation from the deadline
2025
not confirmed
2024
1 d early
2023
33 d early
2022
32 d early
2021
2 d early
2020
31 d early
2019
3 d early
← before the deadline
after the deadline →
Financials · fiscal year 2024, abbreviated schema
Equity
€172k▲ 16.5%
2023 · €148k
2018: €34k
2019: €140k
2020: €207k
2021: €117k
2022: €121k
2023: €148k
2018 → 2024
Total assets
€184k▲ 24.6%
2023 · €148k
2018: €40k
2019: €173k
2020: €259k
2021: €143k
2022: €129k
2023: €148k
2018 → 2024
Net result
€152k▲ 21.0%
2023 · €126k
2018: €22k
2019: €105k
2020: €68k
2021: €97k
2022: €99k
2023: €126k
2018 → 2024
Working capital
€159k▲ 18.9%
2023 · €134k
2018: €32k
2019: €132k
2020: €199k
2021: €111k
2022: €113k
2023: €134k
2018 → 2024
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20202021202220232024Trend
Equity€207k-€117k▼ 43.4%€121k▲ 2.9%€148k▲ 22.4%€172k▲ 16.5%
Operating result€88k-€126k▲ 43.4%€129k▲ 3.1%€164k▲ 26.6%€199k▲ 21.3%
Net result€68k-€97k▲ 43.3%€99k▲ 2.6%€126k▲ 26.8%€152k▲ 21.0%
Turnover and EBIT margin not published: the abbreviated schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result has risen four years in a row; 2024 is 21% above 2023 and is the highest result in the available series.
Balance-sheet composition
2024 in colour, 2023 as the grey bar beneath
Assets €184k
Fixed assets
€13k▼ 6.5%
Current assets
€171k▲ 27.9%
Equity and liabilities €184k
Equity
€172k
Debt
€12k
Debt finances 6.5% of the balance-sheet total.
Key figures and ratios
EBITDA
€202k▲
2023 · €167k
Cash flow
€156k▲
2023 · €129k
Solvency
93.5%▼
2023 · 100.0%
Current ratio
14.33
Quick ratio
14.33
Debt / equity
0.07▲
2023 · 0.00
ROE
88.6%▲
2023 · 85.4%
ROA
82.9%▼
2023 · 85.4%
Interest coverage
130.18▼
2023 · 171.19
Debt
€12k▲
2023 · €0
Debt ≤ 1 year
€12k▲
2023 · €0
Income taxes
€45k▲
2023 · €37k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2024 against 2023
Balance sheet
Code20232024
Assets
Total assets20/58€148k€184k▲
Fixed assets21/28€14k€13k▼
Tangible fixed assets22/27€14k€13k▼
Furniture and vehicles24€14k€13k▼
Current assets29/58€134k€171k▲
Amounts receivable within one year40/41€16k€2k▼
Trade receivables40€915€0▼
Other amounts receivable41€15k€2k▼
Cash at bank and in hand54/58€29k€78k▲
Deferred charges and accrued income490/1€89k€91k▲
Equity and liabilities
Total equity and liabilities10/49€148k€184k▲
Equity10/15€148k€172k▲
Contributions10/11€19k€19k=
Reserves13€129k€153k▲
Non-distributable reserves130/1€0-
Reserves not available under the articles1311€0-
Distributable reserves133€129k€153k▲
Profit (loss) carried forward14€233€631▲
Amounts payable17/49€0€12k▲
Amounts payable within one year42/48€0€12k▲
Trade debts44€0-
Suppliers440/4€0-
Taxes, remuneration and social security45€0€5k▲
Taxes450/3€0€5k▲
Other amounts payable47/48€0€7k▲
Income statement
Code20232024
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€3k€4k▲
Other operating charges640/8€437€359▼
Gross operating margin9900€168k€203k▲
Operating profit (loss)9901€164k€199k▲
Financial income75/76B€0€70▲
Recurring financial income75€0€70▲
Financial charges65/66B€977€2k▲
Recurring financial charges65€977€2k▲
Profit (loss) for the period before taxes9903€163k€197k▲
Income taxes67/77€37k€45k▲
Profit (loss) for the period9904€126k€152k▲
Profit (loss) for the period to be appropriated9905€126k€152k▲
Appropriation of the result
Profit (loss) to be appropriated9906€127k€153k▲
Profit (loss) brought forward from the previous period14P€1k€233▼
Transfer from equity791/2€99k€128k▲
Transfer to equity691/2€127k€152k▲
To other reserves6921€127k€152k▲
Profit to be distributed694/7€99k€128k▲
Return on contributions (dividend)694€99k€128k▲
The notes to these accounts (5 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
2025
30-07
NBB filing
Annual accounts filed
fiscal year 2024 · abbreviated schema
2024
31-12
Financial
Highest result since 2018net €152k ▲21%
Operating result €199k, net result €152k, both a record.
31-12
Financial
Equity above €150kEq €172k ▲16.5%
7 profitable years in a row build equity to €172k.
28-06
NBB filing
Annual accounts filed
fiscal year 2023 · abbreviated schema
2023
29-06
NBB filing
Annual accounts filed
fiscal year 2022 · abbreviated schema
2022
31-12
Financial
Liquidity triplescurrent ratio 14.35
Current ratio from 5.33 to 14.35; short-term debt falls from €26k to €8k.
29-07
NBB filing
Annual accounts filed
fiscal year 2021 · abbreviated schema
2021
30-06
NBB filing
Annual accounts filed
fiscal year 2020 · abbreviated schema
2020
31-12
Financial
Equity above €200kEq €207k ▲48.4%
3 profitable years in a row build equity to €207k.
28-07
NBB filing
Annual accounts filed
fiscal year 2019 · abbreviated schema
2019
31-12
Financial
Equity above €100kEq €140k ▲308%
2 profitable years in a row build equity to €140k.
28-06
NBB filing
Annual accounts filed
fiscal year 2018 · abbreviated schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
4 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Rotselaar · 1 establishment unit since 2018
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Kloosterbroekpad 133111 RotselaarGround area
511 m²
Building footprint
130 m²
Volume, LiDAR
706 m³
Parcel 24123A0435/00G000, Flanders · tallest building 7.9 m, ±2 floors. Linked by address, not a title deed.
1 establishment unit
Dokter Julie BASTIN
since 20182.281.332.013
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 24123A0435/00G000 | Flanders | 511 m² | 1 · 130 m² | 7.9 m · 2 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
Jelema
BE 1002.352.567
Antwerpen · Eq €172k
CRELIKUS
BE 0743.872.214
Diepenbeek · Eq €172k
Dr. WYBAILLIE Elke
BE 1001.474.817
Wervik · Eq €172k
Dr Stéphane BUTS
BE 0564.715.687
Liège · Eq €172k
Dokter HLF
BE 0801.283.148
Antwerpen · Eq €172k
Of 16,621 companies in sector 86220 we hold annual accounts for 7,972. 6,809 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded02-10-2018
Fiscal year end31-12
Activities, NACEBEL
86220Specialist medical practice
Sources
Crossroads Bank for EnterprisesNational Bank · 7 filingsAddress and cadastre registers
Data from official sources, last processed on 15-09-2026. Scores and ratios are computed by Checked and are not a credit decision.